The case for nonsurgical therapy of nonmetastatic penile cancer
The case for nonsurgical therapy of nonmetastatic penile cancerThe case for nonsurgical therapy of nonmetastatic penile cancer, Published online: 27 June 2018; doi:10.1038/s41585-018-0040-yDespite the considerable detrimental effects associated with penectomy, squamous cell carcinoma (SCC) of the penis is most commonly treated with surgery. However, SCC at other locations can be successfully managed using chemotherapy and radiation. Here, Jonathan Tward makes a case for organ-sparing treatments for penile cancer, based on data from treatment of SCC at other body sites.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Jonathan Tward Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Penile Cancer | Skin Cancer | Squamous Cell Carcinoma | Urology & Nephrology